Trillium Therapeutics’ TTI-621 Receives Orphan Drug Designation for the Treatment of Cutaneous T-Cell Lymphoma Pharmaceutical Investing
Moleculin Announces Grant-Funded Collaboration to Expand Understanding of New Discovery Pharmaceutical Investing
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results Pharmaceutical Investing
pSivida Announces FDA Acceptance For Filing of New Drug Application for Durasert Pharmaceutical Investing
Cellectar Biosciences Granted Orphan Drug Designation for CLR 131 to Treat Neuroblastoma Pharmaceutical Investing
Aclaris Therapeutics Announces Positive Update on Phase 2 Results after a 3-month Follow-Up Pharmaceutical Investing
Dova Pharmaceuticals Signs Exclusive Distribution Agreement with Fosun Pharma For Mainland China and Hong Kong Pharmaceutical Investing
